Rheumatoid Arthritis News

Baricitinib monotherapy improves disease control in many patients with rheumatoid arthritis who were did not respond to methotrexate, according to data published in Arthritis Care & Research.

Having an increased genetic risk for rheumatoid arthritis is associated with demonstrating hyperactivity and inattention symptoms from ages 4 to 16 years, as well as lower total IQ and IQ performance at 8 years, according to data published in JAMA Network Open.

Abatacept demonstrated similar 9-year persistence rates as TNF inhibitors when used as a first-line treatment for rheumatoid arthritis, and had superior persistence rates compared with TNF inhibitors when used as a second-line agent, according to data published in Arthritis Research & Therapy.

An algorithm designed to detect Velcro crackles in the lungs demonstrated diagnostic accuracy for detecting interstitial lung disease in patients with rheumatoid arthritis, according to a study published in BMC Pulmonary Medicine.

White blood cell counts and inflammatory markers may hold lower diagnostic utility among patients in an immunosuppressed state who experienced periprosthetic joint infection after total joint arthroplasty, according to published research.

Patients with rheumatoid arthritis treated with tofacitinib experienced efficacy and safety outcomes comparable to patients treated with tofacitinib plus methotrexate, according to findings presented at the EULAR Annual Congress.

Political activism is more accessible than ever thanks to the amplification offered by social media, and rheumatologists can use social media — particularly Twitter — to advocate for the profession and their patients, according to Angus Worthing, MD, private practice rheumatologist and chair of the Government Affairs Committee for the American College of Rheumatology.

Achieving remission in rheumatoid arthritis was associated with an 80% decrease in atherosclerosis incidence, according to findings presented at the EULAR Annual Congress.

Two studies presented at the EULAR Annual Congress revealed gaps between recommended standards of care and the actual care that patients in Europe are receiving for rheumatoid arthritis and systemic lupus erythematosus.

Adults with rheumatoid arthritis and higher measures indicating frailty were more likely to sustain an osteoporotic fracture during 4 years of follow-up vs. similar patients with lower indicators of frailty, according to an analysis of Canadian registry data published in Bone.